961.13(1m)(1m)The controlled substances board shall add a substance to schedule I upon finding that the substance:
961.13(1m)(a) (a) Has high potential for abuse;
961.13(1m)(b) (b) Has no currently accepted medical use in treatment in the United States; and
961.13(1m)(c) (c) Lacks accepted safety for use in treatment under medical supervision.
961.13(2m) (2m)The controlled substances board may add a substance to schedule I without making the findings required under sub. (1m) if the substance is controlled under schedule I of 21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.13 History History: 1971 c. 219; 1995 a. 448 ss. 155, 156, 471; Stats. 1995 s. 961.13.
961.14 961.14 Schedule I. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I:
961.14(2) (2) Synthetic opiates. Any material, compound, mixture or preparation which contains any quantity of any of the following synthetic opiates, including any of their isomers, esters, ethers, esters and ethers of isomers, salts and salts of isomers, esters, ethers and esters and ethers of isomers that are theoretically possible within the specific chemical designation:
961.14(2)(ag) (ag) Acetylmethadol;
961.14(2)(aj) (aj) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide);
961.14(2)(am) (am) Allylprodine;
961.14(2)(b) (b) Alphacetylmethadol (except levo-alphacetylmethadol (LAAM));
961.14(2)(bm) (bm) Alphameprodine;
961.14(2)(c) (c) Alphamethadol;
961.14(2)(cm) (cm) Benzethidine;
961.14(2)(d) (d) Betacetylmethadol;
961.14(2)(dm) (dm) Betameprodine;
961.14(2)(e) (e) Betamethadol;
961.14(2)(em) (em) Betaprodine;
961.14(2)(et) (et) Brorphine;
961.14(2)(f) (f) Clonitazene;
961.14(2)(fm) (fm) Dextromoramide;
961.14(2)(gm) (gm) Diampromide;
961.14(2)(h) (h) Diethylthiambutene;
961.14(2)(hg) (hg) Difenoxin;
961.14(2)(hm) (hm) Dimenoxadol;
961.14(2)(j) (j) Dimepheptanol;
961.14(2)(jm) (jm) Dimethylthiambutene;
961.14(2)(k) (k) Dioxaphetyl butyrate;
961.14(2)(km) (km) Dipipanone;
961.14(2)(m) (m) Ethylmethylthiambutene;
961.14(2)(mm) (mm) Etonitazene;
961.14(2)(n) (n) Etoxeridine;
961.14(2)(nd) (nd) Fentanyl analogs, including any compound, except compounds scheduled elsewhere in this chapter, structurally derived from fentanyl by replacement of the phenyl portion of the phenethyl group by any monocycle whether or not further substituted in or on the monocycle; by substitution in or on the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or nitro groups; by substitution in or on the piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, amino or nitro groups; by replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; by replacement of the N-propionyl group by another acyl group; or by any combination of these modifications. Substances specified under this paragraph include all of the following:
961.14(2)(nd)1. 1. Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2- phenylethyl)-4-piperidinyl]-N-phenylacetamide);
961.14(2)(nd)2. 2. Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide);
961.14(2)(nd)3. 3. Acryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2-propenamide);
961.14(2)(nd)4. 4. Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(nd)5. 5. Alpha-methylthiofentanyl (N-{1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(nd)6. 6. Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(nd)7. 7. Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy- 2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
961.14(2)(nd)8. 8. Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);
961.14(2)(nd)9. 9. Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);
961.14(2)(nd)9m. 9m. Crotonyl Fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2- enamide);
961.14(2)(nd)10. 10. Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);
961.14(2)(nd)10d. 10d. Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
961.14(2)(nd)10p. 10p. 4-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]-butyramide);
961.14(2)(nd)10t. 10t. 4-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
961.14(2)(nd)11. 11. Furanyl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide).
961.14(2)(nd)12. 12. Isobutyryl fentanyl (2-methyl-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-propanamide);
961.14(2)(nd)12w. 12w. Methoxyacetyl fentanyl (2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-acetamide);
961.14(2)(nd)12y. 12y. 3-methylbutyryl fentanyl (N-[3-methyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylbutyramide);
961.14(2)(nd)13. 13. 4-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
961.14(2)(nd)14. 14. 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- piperidinyl]-N-phenylpropanamide);
961.14(2)(nd)15. 15. 3-methylthiofentanyl (N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(nd)16. 16. Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]-acetamide);
961.14(2)(nd)16m. 16m. Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
961.14(2)(nd)16s. 16s. Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
961.14(2)(nd)17. 17. Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
961.14(2)(nd)18. 18. Tetrahydrofuran fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
961.14(2)(nd)19. 19. Thiofentanyl (N-{1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(nd)20. 20. Valeryl fentanyl (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide).
961.14(2)(nm) (nm) Furethidine;
961.14(2)(p) (p) Hydroxypethidine;
961.14(2)(pe) (pe) Isotonitazene;
961.14(2)(pm) (pm) Ketobemidone;
961.14(2)(q) (q) Levomoramide;
961.14(2)(qm) (qm) Levophenacylmorphan;
961.14(2)(r) (r) Morpheridine;
961.14(2)(rg) (rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
961.14(2)(rk) (rk) MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);
961.14(2)(rm) (rm) Noracymethadol;
961.14(2)(s) (s) Norlevorphanol;
961.14(2)(sm) (sm) Normethadone;
961.14(2)(t) (t) Norpipanone;
961.14(2)(tm) (tm) Phenadoxone;
961.14(2)(u) (u) Phenampromide;
961.14(2)(um) (um) Phenomorphan;
961.14(2)(v) (v) Phenoperidine;
961.14(2)(vg) (vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
961.14(2)(vm) (vm) Piritramide;
961.14(2)(w) (w) Proheptazine;
961.14(2)(wm) (wm) Properidine;
961.14(2)(wn) (wn) Propiram;
961.14(2)(x) (x) Racemoramide;
961.14(2)(xr) (xr) Tilidine;
961.14(2)(y) (y) Trimeperidine.
961.14(2)(z) (z) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide).
961.14(3) (3) Substances derived from opium. Any material, compound, mixture or preparation which contains any quantity of any of the following substances derived from opium, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
2019-20 Wisconsin Statutes updated through 2021 Wis. Act 31, through all Orders of the Controlled Substances Board filed before and in effect on June 2, 2021, and through all Supreme Court Orders filed before and in effect on April 15, 2021. Published and certified under s. 35.18. Changes effective after June 2, 2021, other than those made by Supreme Court Order No. 20-07, are designated by NOTES. (Published 6-2-21)